Home›Stocks›TEVA

TEVA — structural market context

Teva Pharmaceutical Industries

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

TEVA short interest & days to cover

SHARES SHORT
34.3M
% OF FLOAT
—
DAYS TO COVER
5.7
CHANGE VS PRIOR
+4.8%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-07-31 (38d ago)

TEVA fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-08-12 · 26d907$36.48
2026-08-04 · 34d177$34.46
2026-08-03 · 35d588$35.01

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

TEVA insider buying and selling (Form 4)

Last 12 months, open-market only: 0 purchases · 4 sales

InsiderTypeSharesValueFiled
Weiss Amir · officer: Chief Accounting OfficerSell (S)7K$261K2026-08-25
Weiss Amir · officer: Chief Accounting OfficerSell (S)3K$94K2026-08-25
Satchi-Fainaro Ronit · directorSell (S)415$15K2026-08-25
Lippman Evan · officer: EVP, Business DevelopmentSell (S)19K$680K2026-08-19

SEC Form 4 filings, open-market purchases and sales only (codes P and S); grants and option exercises excluded. Attributed public records.

TEVA analyst ratings — with each firm's measured accuracy

FirmActionRatingFirm 5d hit rate*Published
UBSholdBuy48.3% (n=60)2026-09-04
UBSprice_target—48.3% (n=60)2026-09-04

*Rating actions from public feeds. Where shown, the firm's 5-day hit rate is our measured backtest (firms with >=30 graded calls); a historical hit rate describes past calls, it does not grade this one.

Frequently asked questions

Are insiders buying TEVA?
In the last 12 months of SEC Form 4 filings, TEVA recorded 0 open-market insider purchases and 4 open-market sales (codes P and S; grants and option exercises excluded). These are attributed public records — information, not instruction.
What do analysts say about TEVA?
The most recent action: UBS hold to Buy on 2026-09-04. In our backtest, UBS's 5-day hit rate across 60 graded calls is 48.3%. We show each firm's measured record next to its ratings; a historical hit rate describes past calls and does not grade this one.
Is this page telling me to buy or sell TEVA?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

This is the teaser.

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.